Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiyao Ren

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Annals of Hematology|September 18, 2025
Prime-time for LncRNA signatures in acute myeloid leukemia?Zhiyao Ren, Barbara De Moerloose, Tim Lammens
The Journal of Gene Medicine|February 2, 2022
The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axisYunfeng Xu, Zhiyao Ren, Xin Wang, et al.
Ear, Nose, & Throat Journal|October 21, 2021
Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell CarcinomaYanxun Han, Zhiyao Ren, Yuchen Liu, et al.
Environmental Science and Pollution Research International|January 7, 2022
KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancerZhiyao Ren, Yunfeng Xu, Xin Wang, et al.
International Journal of Molecular Sciences|June 19, 2024
Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic TargetsNiels Vercouillie, Zhiyao Ren, Eva Terras, et al.
Blood Advances|April 19, 2024
A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AMLZhiyao Ren, Jolien Vanhooren, Charlotte Derpoorter, et al.
Environmental Toxicology|November 18, 2022
KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axisXin Wang, Zhiyao Ren, Yunfeng Xu, et al.
Cancer Cell International|February 24, 2024
Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinibBei Zhang, Yan Chen, Xinqi Chen, et al.
Iscience|February 27, 2023
CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasisBei Zhang, Zhiyao Ren, Hongmei Zheng, et al.
Frontiers in Medicine|July 18, 2022
Anti-colon Cancer Effects of <i>Dendrobium officinale</i> Kimura & Migo Revealed by Network Pharmacology Integrated With Molecular Docking and Metabolomics StudiesShengchang Tao, Jinyan Li, Huan Wang, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Annals of Hematology|September 18, 2025
Prime-time for LncRNA signatures in acute myeloid leukemia?Zhiyao Ren, Barbara De Moerloose, Tim Lammens
The Journal of Gene Medicine|February 2, 2022
The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axisYunfeng Xu, Zhiyao Ren, Xin Wang, et al.
Ear, Nose, & Throat Journal|October 21, 2021
Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell CarcinomaYanxun Han, Zhiyao Ren, Yuchen Liu, et al.
Environmental Science and Pollution Research International|January 7, 2022
KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancerZhiyao Ren, Yunfeng Xu, Xin Wang, et al.
International Journal of Molecular Sciences|June 19, 2024
Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic TargetsNiels Vercouillie, Zhiyao Ren, Eva Terras, et al.
Blood Advances|April 19, 2024
A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AMLZhiyao Ren, Jolien Vanhooren, Charlotte Derpoorter, et al.
Environmental Toxicology|November 18, 2022
KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axisXin Wang, Zhiyao Ren, Yunfeng Xu, et al.
Cancer Cell International|February 24, 2024
Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinibBei Zhang, Yan Chen, Xinqi Chen, et al.
Iscience|February 27, 2023
CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasisBei Zhang, Zhiyao Ren, Hongmei Zheng, et al.
Frontiers in Medicine|July 18, 2022
Anti-colon Cancer Effects of <i>Dendrobium officinale</i> Kimura & Migo Revealed by Network Pharmacology Integrated With Molecular Docking and Metabolomics StudiesShengchang Tao, Jinyan Li, Huan Wang, et al.
Pageof 4